KCNA2 抗体
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| KCNA2 抗体 (C-Term, Cytosolic) (FL550) | 大鼠 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) (FL594) | 大鼠 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) (FL650) | 大鼠 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) (FL490) | 大鼠 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) | 人 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Intracellular) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (Alexa Fluor 680) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (Alexa Fluor 555) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (Alexa Fluor 647) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (Alexa Fluor 750) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (Alexa Fluor 488) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (Alexa Fluor 594) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) | 大鼠, 小鼠 | 豚鼠 Polyclonal |
|
|
|
| KCNA2 抗体 (AA 437-493) | 斑马鱼 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (Biotin) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- KO Validated
- 适用
- 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- K14-16
- 标记
- FL550
- 抗体亚型
- IgG2b
- 抗原表位
- AA 428-499, C-Term, Cytosolic
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- KO Validated
- 适用
- 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- K14-16
- 标记
- FL594
- 抗体亚型
- IgG2b
- 抗原表位
- AA 428-499, C-Term, Cytosolic
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- KO Validated
- 适用
- 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- K14-16
- 标记
- FL650
- 抗体亚型
- IgG2b
- 抗原表位
- AA 428-499, C-Term, Cytosolic
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- KO Validated
- 适用
- 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- K14-16
- 标记
- FL490
- 抗体亚型
- IgG2b
- 抗原表位
- AA 428-499, C-Term, Cytosolic
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- L76-36
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 428-499, C-Term, Cytosolic
- M (Molecule: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IC (Immunochromatography: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 417-499, C-Term, Intracellular
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 451-479, C-Term
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 豚鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
- WB (Western Blotting: 所列应用)
- 适用
- 斑马鱼
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 437-493
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Latest Publications for our KCNA2 抗体
: "Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy." in: Nature medicine, Vol. 21, Issue 1, pp. 19-26, (2015) (PubMed).
: "Use-dependent activation of neuronal Kv1.2 channel complexes." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 8, pp. 3515-24, (2015) (PubMed).
: "De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. ..." in: Nature genetics, Vol. 47, Issue 4, pp. 393-9, (2015) (PubMed).
: "Sialylation regulates brain structure and function." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 29, Issue 7, pp. 3040-53, (2015) (PubMed).
: "Human Neuroma-in-Continuity Contains Focal Deficits in Myelination." in: Journal of neuropathology and experimental neurology, Vol. 74, Issue 9, pp. 901-911, (2015) (PubMed).
: "Selective down-regulation of KV2.1 function contributes to enhanced arterial tone during diabetes." in: The Journal of biological chemistry, Vol. 290, Issue 12, pp. 7918-29, (2015) (PubMed).
: "BK Channels Localize to the Paranodal Junction and Regulate Action Potentials in Myelinated Axons of Cerebellar Purkinje Cells." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 18, pp. 7082-94, (2015) (PubMed).
: "Singular localization of sodium channel β4 subunit in unmyelinated fibres and its role in the striatum." in: Nature communications, Vol. 5, pp. 5525, (2014) (PubMed).
: "Ankyrin-G directly binds to kinesin-1 to transport voltage-gated Na+ channels into axons." in: Developmental cell, Vol. 28, Issue 2, pp. 117-31, (2014) (PubMed).
Aliases for KCNA2 抗体
potassium voltage-gated channel subfamily A member 2 (KCNA2) 抗体potassium channel, voltage gated shaker related subfamily A, member 1 (kcna1) 抗体
potassium voltage-gated channel, shaker-related subfamily, member 2 (Kcna2) 抗体
potassium voltage-gated channel subfamily A member 2 (Kcna2) 抗体
potassium voltage-gated channel subfamily A member 2 (LOC100537815) 抗体
potassium channel, voltage gated shaker related subfamily A, member 2 S homeolog (kcna2.S) 抗体
Akr6a4 抗体
BK2 抗体
ENSMUSG00000074335 抗体
Gm10672 抗体
HBK5 抗体
HK4 抗体
HUKIV 抗体
k(v)1.2 抗体
Kca1-2 抗体
KCNA2 抗体
kcna2 抗体
kcna2-a 抗体
KV1.2 抗体
Kv1.2 抗体
kv1.2 抗体
Mk-2 抗体
MK2 抗体
NGK1 抗体
RBK2 抗体
XSha2 抗体